Seeking women diagnosed with low-grade serous cancer of the ovary or peritoneum for a study of an investigational drug to reduce the risk of the cancer progressing or returning.
Participants in this study will be randomly assigned to get either the usual chemotherapy drugs to treat their cancer and the investigational drug or only the investigational drug without chemotherapy unless the cancer progresses or returns.
What we're hoping for
We are studying whether use of an investigational drug by itself or in combination with the usual treatment for low-grade serous ovarian or peritoneal cancer reduces the risk of the cancer growing or spreading.
ClinicalTrials.gov Identifier: NCT04095364